Affiliations: [a] Department of Pediatrics, College of Medicine, Jouf UniversitySakakah, Saudi Arabia
| [b]
Department of Pediatrics, Faculty of Medicine, Tanta University, Tanta, Egypt
| [c]
Department of Pediatrics, College of Medicine, Assiut University, Assiut, Egypt
| [d]
Department of Pediatrics, El Menshawy General Hospital, Tanta, Egypt
Correspondence:
[*]
Address for correspondences: Mohamed Shawky Elfarargy, MD, Associate professor of Paediatrics, College of Medicine, Jouf University, KSA & Professor of Paediatrics, Faculty of Medicine, Tanta University, Egypt. 64 El Fatah Street, Tanta, Egypt. Tel.: +201005171750/966560083771, Emails: farargy2009@hotmail.com, mselfarargy@ju.edu.sa.
Abstract: Coronavirus disease 2019 (COVID-19) is considered an infectious disease which is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neonatal COVID-19 had been occurred in many countries which would indicate the need of effective and safe treatment for these vulnerable group. In this study, we showed symptoms of corona virus in neonates, investigation of coronavirus in neonates and radiological features of neonatal COVID-19. In addition, we discussed management of neonates with COVI-19, antiviral treatment, monoclonal antibodies administration, immunomodulatory therapy, antibiotics, vitamins, and minerals in the treatment of neonatal COVID-19, and also telemedicine in neonatal COVID-19 and feeding the newborn of COVID-19 mother. We also discussed multisystem inflammatory syndrome in neonates (MIS-N), management of affected COVID-19 neonates and discussion of the complication of the neonatal COVID-19. We further discussed the methods of dealing with COVID-19 neonates and the research done on the neonatal COVID-19 treatment.
